Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer.
Sci Rep. 2024 Jan 3;14(1):345. doi: 10.1038/s41598-023-48546-y.
Sci Rep. 2024.
PMID: 38172168
Free PMC article.
Timing of Adjuvant Durvalumab Initiation Is Not Associated With Outcomes in Stage III Non-small Cell Lung Cancer.
Bryant AK, Sankar K, Strohbehn GW, Zhao L, Elliott D, Daniel V, Ramnath N, Green MD.
Bryant AK, et al.
Int J Radiat Oncol Biol Phys. 2022 May 1;113(1):60-65. doi: 10.1016/j.ijrobp.2021.12.176. Epub 2022 Feb 1.
Int J Radiat Oncol Biol Phys. 2022.
PMID: 35115216
Free PMC article.
Item in Clipboard
Clinical Determinants of Durable Clinical Benefit of Pembrolizumab in Veterans With Advanced Non-Small-Cell Lung Cancer.
Qin A, Street L, Cease K, Viglianti BL, Warren EH, Zhao L, Ramnath N.
Qin A, et al.
Clin Lung Cancer. 2017 Sep;18(5):559-564. doi: 10.1016/j.cllc.2017.01.012. Epub 2017 Feb 9.
Clin Lung Cancer. 2017.
PMID: 28366756
Free PMC article.
Clinical Trial.
Item in Clipboard
Epidermal Growth Factor Receptor Mutations Carried in Extracellular Vesicle-Derived Cargo Mirror Disease Status in Metastatic Non-small Cell Lung Cancer.
Purcell E, Owen S, Prantzalos E, Radomski A, Carman N, Lo TW, Zeinali M, Subramanian C, Ramnath N, Nagrath S.
Purcell E, et al.
Front Cell Dev Biol. 2021 Oct 6;9:724389. doi: 10.3389/fcell.2021.724389. eCollection 2021.
Front Cell Dev Biol. 2021.
PMID: 34692681
Free PMC article.
Item in Clipboard
Cite
Cite